TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Kappa Bioscience AS
Closing information (x1000 NOK)
Closing information | 2022/12 | 2021/12 | 2020/12 (consolidated) |
Turnover |
292,105
|
232,071
|
296,226 |
Financial expenses |
22,245
|
43,945
|
16,625 |
Earnings before taxes |
67,303
|
68,965
|
86,724 |
Total assets |
470,980
|
358,271
|
289,544 |
Current assets |
214,758
|
257,079
|
194,647 |
Current liabilities |
145,652
|
91,208
|
90,028 |
Equity capital |
254,083
|
230,199
|
191,064 |
- share capital |
1,521
![]() |
1,521
![]() |
1,521 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 (consolidated) |
Solvency |
53.9%
|
64.3%
|
66.0% |
Turnover per employee | |||
Profit as a percentage of turnover |
23.0%
|
29.7%
|
29.3% |
Return on assets (ROA) |
19.0%
|
31.5%
|
35.7% |
Current ratio |
147.4%
|
281.9%
|
216.2% |
Return on equity (ROE) |
26.5%
|
30.0%
|
45.4% |
Change turnover |
60,034
|
-64,155
|
93,239 |
Change turnover % | 26% | 46% | |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.